MYC and colorectal carcinoma: Studies have also elucidated that LINRIS inhibits IGF2BP2 degradation in CRC HCT116 cells by inhibiting K139 ubiquitination, thereby promoting downstream MYC‐mediated glycolysis and tumor proliferation.